Ubiquitin proteolytic system: Focus on SUMO

Expert Review of Proteomics

Volumn 5, Issue 1, 2008, Pages 121-135

  Wilson, Van G ^a   Heaton, Phillip R ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Cross talk; Mass spectrometry; Proteomics signature tag; STUbL; SUMOeome; Tandem affinity purification; Ubl

Indexed keywords

LYSINE; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; SUMO 4 PROTEIN; SUMO PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; BINDING AFFINITY; CAENORHABDITIS ELEGANS; CELL FUNCTION; COVALENT BOND; ENZYME SUBSTRATE; HUMAN; MASS SPECTROMETRY; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN TARGETING; PROTEOMICS; REVIEW; SUMOYLATION;

VERTEBRATA;

EID: 39649100680     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.5.1.121     Document Type: Review

References (92)

1. Herrmann J, Lerman LO, Lerman A. Ubiquitin and ubiquitin-like proteins in protein regulation. Circ. Res. 100, 1276-1291 (2007).
2. Melchior F. SUMO - nonclassical ubiquitin. Ann. Rev. Cell Develop. Biol. 16, 591-626 (2000).
3. Desterro JM, Thomson J, Hay RT. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417, 297-300 (1997).
4. Saitoh H, Sparrow DB, Shiomi T et al. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr. Biol. 8, 121-124 (1998).
5. Kerscher O. SUMO junction - what's your function? New insights through SUMO-interacting motifs. EMBO Rep. 8, 550-555 (2007).
6. Hay RT. SUMO: a history of modification. Mol. Cell 18, 1-12 (2005).
7. Seeler JS, Bischof O, Nacerddine K, Dejean A. SUMO, the three Rs and cancer. Curr. Top. Microbiol. Immunol. 313, 49-71 (2007).
8. Gong LM, Millas S, Maul GG, Yeh ETH. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275, 3355-3359 (2000).
9. Kim KI, Baek SH, Jeon YJ et al. A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J. Biol. Chem. 275, 14102-14106 (2000).
10. Best JL, Ganiatsas S, Agarwal S et al. SUMO-1 protease-1 regulates gene transcription through PML. Mol. Cell 10, 843-855 (2002).
11. Nishida T, Kaneko F, Kitagawa M, Yasuda H. Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat Axam, which is an Axin-binding protein promoting β-catenin degradation. J. Biol. Chem. 276, 39060-39066 (2001).
12. Kadoya T, Yamamoto H, Suzuki T et al. Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of β-catenin. Mol. Cell. Biol. 22, 3803-3819 (2002).
13. Saitoh H, Pu RT, Dasso M. SUMO-1: wrestling with a new ubiquitin-related modifier. Trends Biochem. Sci. 22, 374-376 (1997).
14. Yeh ET, Gong L, Kamitani T. Ubiquitin-like proteins: new wines in new bottles. Gene 248, 1-14 (2000).
15. Jones D, Crowe E, Stevens TA, Candido EPM. Functional and phylogenetic analysis of the ubiquitylation system in Caenorhabditis elegans: ubiquitin-conjugating enzymes, ubiquitin-activating enzymes, and ubiquitin-like proteins. Genome Biol. 3, 2.1-2.15 (2001).
16. Nacerddine K, Lehembre F, Bhaumik M et al. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Develop. Cell 9, 769-779 (2005).
17. Zhao J. Sumoylation regulates diverse biological processes. Cell. Mol. Life Sci. 19, 350-355 (2007).
18. Jakobs A, Koehnke J, Himstedt F et al. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation. Nat. Methods 4, 245-250 (2007).
19. Lane CS. Mass spectrometry-based proteomics in the life sciences. Cell. Mol. Life Sci. 62, 848-869 (2005).
20. Lubec G, Afjehi-Sadat L. Limitations and pitfalls in protein identification by mass spectrometry. Chem. Rev. 107, 3568-3584 (2007).
21. Li TW, Evdokimov E, Shen RF et al. Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis. Proc. Natl Acad. Sci. USA 101, 8551-8556 (2004).
22. Zhao YM, Kwon SW, Anselmo A, Kaur K, White MA. Broad spectrum identification of cellular small ubiquitin-related modifier (SUMO) substrate proteins. J. Biol. Chem. 279, 20999-21002 (2004). • First published report using mass spectrometry (MS) to identify sumoylated proteins.
23. 2+-charged talon resin. Protein Expr. Purif. 54, 289-294 (2007).
24. Li TW, Santockyte R, Shen RF et al. A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers. Arch. Biochem. Biophys. 453, 70-74 (2006).
25. Vertegaal ACO, Andersen JS, Ogg SC et al. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell. Proteomics 5, 2298-2310 (2006). •• Quantitative proteomics using stable arginine isotopes applied to SUMO2 and SUMO2.
26. Panse VG, Hardeland U, Werner T, Kuster B, Hurt E. A proteome-wide approach identifies sumoylated substrate proteins in yeast. J. Biol. Chem. 279, 41346-41351 (2004).
27. Denison C, Kirkpatrick DS, Gygi SP. Proteomic insights into ubiquitin and ubiquitin-like proteins. Curr. Opin. Chem. Biol. 9, 69-75 (2005).
28. Ganesan AK, Kho Y, Kim SC et al. Broad spectrum identification of SUMO substrates in melanoma cells. Proteomics 7, 2216-2221 (2007).
29. Hannich JT, Lewis A, Kroetz MB et al. Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J. Biol. Chem. 280, 4102-4110 (2005).
30. Wykoff DD, O'Shea EK. Identification of sumoylated proteins by systematic immunoprecipitation of the budding yeast proteome. Mol. Cell. Proteomics 4, 73-83 (2005).
31. Rosas-Acosta G, Russell WK, Deyrieux A, Russell DH, Wilson VG. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol. Cell. Proteomics 4, 56-72 (2005). •• First application of tandem affinity purification-tagged SUMO and MS to mammalian cells. Also compared SUMO1 and SUMO3.
32. Zhou W, Ryan JJ, Zhou H. Global analyses of sumoylated proteins in Saccharomyces cerevisiae - induction of protein sumoylation by cellular stresses. J. Biol. Chem. 279, 32262-32268 (2004).
33. Vertegaal ACO, Ogg SC, Jaffray E et al. A proteomic study of SUMO-2 target proteins. J. Biol. Chem. 279, 33791-33798 (2004). • First proteomics report on SUMO2 substrates.
34. Wohlschlegel JA, Johnson ES, Reed SI, Yates JR. Global analysis of protein sumoylation in Saccharomyces cerevisiae. J. Biol. Chem. 279, 45662-45668 (2004).
35. Manza LL, Codreanu SG, Stamer SL et al. Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem. Res. Toxicol. 17, 1706-1715 (2004). •• First application of proteomics to evaluate the sumoylation response to various stress conditions.
36. Oh YH, Hong MY, Jin Z et al. Chip-based analysis of SUMO (small ubiquitin-like modifier) conjugation to a target protein. Biosens. Bioelect. 22, 1260-1267 (2007). • Proof-of-principle for chip-based analysis of sumoylation.
37. Gocke CB, Yu HT, Kang JS. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. J. Biol. Chem. 280, 5004-5012 (2005).
38. Yan J, Yang XP, Kim YS, Joo JH, Jetten AM. RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation. Biochem. Biophys. Res. Commun. 362, 132-138 (2007).
39. Gong L, Yeh ETH. Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J. Biol. Chem. 281, 15869-15877 (2006).
40. Mikolajczyk J, Drag M, Bekes M et al. Small ubiquitin-related modifier (SUMO)-specific proteases - profiling the specificities and activities of human SENPs. J. Biol. Chem. 282, 26217-26224 (2007).
41. Saitoh H, Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252-6258 (2000).
42. Deyrieux AF, Rosas-Acosta G, Ozbun MA, Wilson VG. Sumoylation dynamics during keratinocyte differentiation. J. Cell. Sci. 120, 125-136 (2007).
43. Ayaydin F, Dasso M. Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol. Biol. Cell 15, 5208-5218 (2004).
44. Langereis MA, Rosas-Acosta G, Mulder K, Wilson VG. Production of sumoylated proteins using a baculovirus expression system. J. Virol. Meth. 139, 189-194 (2007).
45. Kurepa J, Walker JM, Smalle J et al. The small ubiquitin-like modifier (SUMO) protein modification system in Arabidopsis - accumulation of SUMO1 and -2 conjugates is increased by stress. J. Biol. Chem. 278, 6862-6872 (2003).
46. Bossis G, Melchior F. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol. Cell 21, 349-357 (2006).
47. Riquelme C, Barthel KK, Qin XF, Liu X. Ubc9 expression is essential for myotube formation in C2C12. Exp. Cell Res. 312(11), 2132-2141 (2006).
48. Shao RJ, Rung E, Weijdegard B, Billig H. Induction of apoptosis increases SUMO-1 protein expression and conjugation in mouse periovulatory granulosa cells in vitro. Mol. Reprod. Dev. 73, 50-60 (2006).
49. Smolen GA, Vassileva MT, Wells J, Matunis MJ, Haber DA. SUMO-1 modification of the Wilms' tumor suppressor WT1. Cancer Res. 64, 7846-7851 (2004).
50. Alarcon-Vargas D, Ronai Z. SUMO in cancer-wrestlers wanted. Cancer Biol. Ther. 1, 237-242 (2002).
51. Mo YY, Yu YN, Theodosiou E, Ee PLR, Beck WT. A role for Ubc9 in tumorigenesis. Oncogene 24, 2677-2683 (2005).
52. Baek SH. A novel link between SUMO modification and cancer metastasis. Cell Cycle 5, 1492-1495 (2006).
53. Il Kim K, Baek SH. SUMOylation code in cancer development and metastasis. Mol. Cell 22, 247-253 (2006).
54. Wu FT, Mo YY. Ubiquitin-like protein modifications in prostate and breast cancer. Front. Biosci. 12, 700-711 (2007).
55. Karamouzis M, Konstantinopoulos P, Badra F, Papavassiliou A. SUMO and estrogen receptors in breast cancer. Breast Cancer Res. Treat. 107(2), 195-210 (2007).
56. Kamitani T, Kito K, Nguyen HP et al. Identification of three major sentrinization sites in PML. J. Biol. Chem. 273, 26675-26682 (1998).
57. Rangasamy D, Woytek K, Khan SA, Wilson VG. SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation. J. Biol. Chem. 275, 37999-38004 (2000).
58. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135-141 (2002).
59. Chung TL, Hsiao HH, Yeh YY et al. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein - definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides. J. Biol. Chem. 279, 39653-39662 (2004).
60. Cooper HJ, Tatham MH, Jaffray E et al. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 AutoSUMOylation reaction. Anal. Chem. 77, 6310-6319 (2005).
61. Pedrioli PGA, Raught B, Zhang XD et al. Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software. Nat. Methods 3, 533-539 (2006).
62. Knuesel M, Cheung HT, Hamady M, Barthel KKB, Liu XD. A method of mapping protein sumoylation sites by mass spectrometry using a modified small ubiquitin-like modifier 1 (SUMO-1) and a computational program. Mol. Cell. Proteomics 4, 1626-1636 (2005).
63. Wohlschlegel JA, Johnson ES, Reed SI, Yates JR. Improved identification of SUMO attachment sites using C-terminal SUMO mutants and tailored protease digestion strategies. J. Proteome Res. 5, 761-770 (2006).
64. Ulrich HD. Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest. Trends Cell Biol. 15, 525-532 (2005).
65. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of I?B? inhibits NF-κB activation. Mol. Cell 2, 233-239 (1998).
66. Lin X, Liang M, Liang YY, Brunicardi FC, Feng XH. SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J. Biol. Chem. 278, 31043-31048 (2003).
67. Steffan JS, Agrawal N, Pallos J et al. SUMO modification of Huntingtin and Huntington's disease pathology. Science 304, 100-104 (2004).
68. Kerscher O, Felberbaum R, Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Ann. Rev. Cell Develop. Biol. 22, 159-180 (2006).
69. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. Sequential modification of NEMO/IKK gamma by SUMO-1 and ubiquitin mediates NF-?B activation by genotoxic stress. Cell 115, 565-576 (2003).
70. Kannouche PL, Wing J, Lehmann AR. Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol. Cell 14, 491-500 (2004).
71. Papouli E, Chen SH, Davies AA et al. Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. Mol. Cell 19, 123-133 (2005).
72. Nathan D, Ingvarsdottir K, Sterner DE et al. Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev. 20, 966-976 (2006).
73. Shiio Y, Eisenman RN. Histone sumoylation is associated with transcriptional repression. Proc. Natl Acad. Sci. USA 100, 13225-13230 (2003).
74. Heun P. SUMOrganization of the nucleus. Curr. Opin. Cell Biol. 19, 350-355 (2007).
75. Xirodimas DP, Chisholm J, Desterro JMS, Lane DP, Hay RT. P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Lett. 528, 207-211 (2002).
76. Buschmann T, Lerner D, Lee CG, Ronai Z. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9. J. Biol. Chem. 276, 40389-40395 (2001).
77. Agrawal A, Yang JH, Murphy RF, Agrawal DK. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer. Exp. Mol. Path. 81, 115-122 (2006).
78. Carter S, Bischof O, Dejean A, Vousden KH. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat. Cell Biol. 9, 428-435 (2007).
79. Miyauchi Y, Yogosawa S, Honda R, Nishida T, Yasuda H. Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes. J. Biol. Chem. 277, 50131-50136 (2002).
80. Lee MH, Lee SW, Lee EJ et al. SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination. Nat. Cell Biol. 8, U1424-U1472 (2006).
81. Um JW, Chung KC. Functional modulation of parkin through physical interaction with SUMO-1. J. Neuro. Res. 84, 1543-1554 (2006).
82. Um JW, Min DS, Rhim H et al. Parkin ubiquitinates and promotes the degradation of RanBP2. J. Biol. Chem. 281, 3595-3603 (2006).
83. Pichler A, Knipscheer P, Oberhofer E et al. SUMO modification of the ubiquitin-conjugating enzyme E2-25K. Nat. Struct. Mol. Biol. 12, 264-269 (2005).
84. de Pril R, Fischer DF, Roos RA, van Leeuwen FW. Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases. Mol. Cell. Neurosci. 34, 10-19 (2007).
85. Pungaliya P, Kulkarni D, Park HJ et al. TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins. J. Proteome Res. 6, 3918-3923 (2007). • First example of a dual function E3 ligase that acts with either SUMO or ubiquitin.
86. Rajendra R, Malegaonkar D, Pungaliya P et al. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. J. Biol. Chem. 279, 36440-36444 (2004).
87. Weger S, Hammer E, Heilbronn R. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo. FEBS Lett. 579, 5007-5012 (2005).
88. Zhao XL, Blobel G. A SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization. Proc. Natl Acad. Sci. USA 102, 9086-9086 (2005).
89. Prudden J, Pebernard S, Raffa G et al. SUMO-targeted ubiquitin ligases in genome stability. EMBO J. 26, 4089-4101 (2007). •• First identification of SUMO-targeted ubiquitin ligases.
90. Sun H, Leverson JD, Hunter T. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J. 26, 4102-4112 (2007). •• First identification of SUMO-targeted ubiquitin ligases.
91. Xie Y, Kerscher O, Kroetz MB et al. The yeast HEX3-SLX8 heterodimer is a ubiquitin ligase stimulated by substrate sumoylation. J. Biol. Chem. 282, 34176-34184 (2007).
92. Uzunova K, Gottsche K, Miteva M et al. Ubiquitin-dependent proteolytic control of SUMO conjugates. J. Biol. Chem. 282, 34167-34175 (2007).